Inhibrx, Inc. revenue breakdown overview

Inhibrx, Inc. revenue for the last year amounted to 1.80 M USD, the most of which — 1.80 M USD — came from its highest performing source at the moment, Biological Therapeutic Candidates, the year earlier bringing 2.19 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Inhibrx, Inc. 1.80 M USD, and the year before that — 2.19 M USD.